Full-Time

Senior Product Marketing Manager

Confirmed live in the last 24 hours

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell genetic information for diagnostics

Biotechnology
Healthcare

Compensation Overview

$143.2k - $214.8kAnnually

+ Equity Grant + Bonus Eligible

Senior, Expert

No H1B Sponsorship

Remote in USA

Preferred location is Seattle, but the position is fully remote.

Category
General Marketing
Growth Marketing
Growth & Marketing
Required Skills
Market Research
Requirements
  • Bachelor’s degree plus 12 years of related experience, or master’s degree plus 10 years of related experience
  • Minimum of 8 years of experience working on a Marketing team in a highly regulated healthcare environment (e.g., diagnostics, therapeutics, medical device); agency-side experience may be applicable
  • Minimum of 3 years of experience in oncology / hematology / immunology
  • Demonstrated success planning and owning the execution of complex marketing strategies and tactics, including some combination of personal and non-personal / digital promotion, peer-to-peer and medical education, congress planning, market research, patient advocacy engagement, and omnichannel digital strategy (including CRM) as well as related performance analytics
  • Significant experience managing external vendors (including agency of record) to deliver scoped projects on-time and on-budget
  • Experience leading or directly supporting cross-functional product launch planning work streams
  • Balances “big picture” strategic thinking with efficient tactical planning and execution
  • An ability to analyze and interpret scientific publications in order to turn clinical data into compelling promotional narratives
  • Flexible and proactive approach including a strong personal drive and desire for feedback
  • Refined interpersonal skills, professional maturity, and good judgment; capable of communicating with and facilitating decisions involving a diverse group of individuals
  • Strong team player; highly effective in partnering cross-functionally and influencing without authority
  • Effective self-starter and project leader; capable of working autonomously and collaboratively to advance the broader team toward agreed-upon goals
  • Ability to clarify and overcome ambiguity; proven structured and unstructured problem-solver
  • Engages in regular self-assessment and works to reinforce strengths and mitigate weaknesses
  • Excellent written and oral communication and presentation skills; persuasive, engaging, and clinically credible when presenting and working with internal and external stakeholders
  • Dynamically manages priorities and workload to support functional and organizational goals
  • A passion for the healthcare field and the power of technology to improve patient lives; maintains a patient-centric attitude and approach to all work
Responsibilities
  • Partner with clonoSEQ Marketing leadership to develop impactful annual business plans for the function, including budgets and tactical plans
  • Lead patient marketing tactical efforts from conception to delivery in order to educate patients and advocacy partners on the clinical value of clonoSEQ leveraging a data-driven approach
  • Collaborate closely with Sales, Medical Affairs, Customer Operations, Market Access, Corporate Communications, Finance, Legal, Regulatory, and other key stakeholders to execute go-to-market strategies and multi-platform tactical plans in support of new product offerings
  • Manage agency partners and vendors on marketing collateral projects, providing strategic direction, content feedback, and end-to-end project management
  • Establish, regularly evaluate, and socialize key patient audience KPIs with team, manager, and Commercial team leadership to ensure consistent alignment between ongoing work and defined business objectives
  • Accomplish business objectives by managing all projects and/or external vendors within specified budget and timeline
  • Partner with Sales Training to ensure optimal rollout and execution of field-based initiatives
  • Participate in field ride-a-longs to better understand promotional opportunities and challenges
  • Proactively maintains a broad understanding of the evolving market landscape, scientific advances, and industry trends
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies uses advanced data algorithms to analyze immune cell genetics and generates revenue through partnerships with pharmaceutical companies, licensing technology, and offering diagnostic services. Their goal is to advance healthcare by leveraging immune system data to develop better therapies and diagnostic tools.

Company Stage

IPO

Total Funding

$395.8M

Headquarters

Seattle, Washington

Founded

2009

Growth & Insights
Headcount

6 month growth

-5%

1 year growth

-11%

2 year growth

-15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strong partnerships with pharmaceutical companies enhance revenue and innovation.
  • Recent investments indicate confidence in Adaptive's growth potential.
  • Integration with Epic could streamline healthcare diagnostics.

What critics are saying

  • Increased competition from startups focusing on large language models.
  • Potential conflicts from partnership with EndoSound on endoscopy device.
  • Regulatory challenges in collaboration with BeiGene for clonoSEQ assay.

What makes Adaptive Biotechnologies unique

  • Pioneers in immune-driven medicine, leveraging adaptive immune system for diagnostics.
  • FDA-authorized clonoSEQ test for minimal residual disease in blood cancers.
  • Unique focus on decoding immune cell receptors for better diagnostics and treatments.

Help us improve and share your feedback! Did you find this helpful?